Time flies, and in the blink of an eye, a few days have passed.

Changhua Pharmaceutical Factory's third new drug, Tharoly, has been officially put on sale yesterday.

Now the Thawing Spirit is sold in a box of ten pills, and in Liu's Pharmacy, a box of Thawing Ling is priced at 200 yuan per box, that is, a single Thawing Spirit is 20 yuan per pill.

One milliliter of healing potion can produce 5 Thawing Spirits, and the cost of one Thawing Spirit alone requires 10 pieces, plus about 2 pieces of medicinal materials with other ingredients, and the R&D costs are evenly distributed to Thawing Spirits, so the cost of a single Thawing Spirit is almost 16 yuan.

The exclusive agency right of Unfrozen Ling is fully handed over to Liu's Group, and Liu's Group will put it on the shelves for sale. But this time, the cooperation agreement between Changhua Pharmaceutical Factory and Liu's Group is already different from before.

Because Changhua Pharmaceutical Factory handed over the thawing spirit to the Liu Group at cost price, and then the production cost of the thawing spirit was removed, and the Changhua Pharmaceutical Factory and the Liu Group shared the profits equally.

The cost price is 16 pieces of thawing spirit, and the final retail price is 20 pieces per pill, which seems to be very expensive.

However, people who really understand the cost of R&D of a new drug will think that the price of Changhua Pharmaceutical Factory is already very low.

Because the R&D cost of any new drug often requires billions of dollars, and it takes an average of 12 years for a new drug to be put on the medicine cabinet from the initial laboratory research to the final placement in the medicine cabinet for sale, and the new drug may not be successfully developed, and the probability of failure is very high, and the risk is not small.

Some of the world's leading pharmaceutical companies are developing their own new drugs.

It's like AstraZeneca. Between 1997 and 2011, R&D spending was about $58 billion. But in the interim. Only five new drugs were approved, so that on average, each new drug spent a whopping $11.8 billion on research and development.

On average, the biopharmaceutical giant Amgen spent the least on new drug development, with nine new drugs approved between 1997 and 2011, and its cost to approve a new drug was about $3.7 billion.

If it is only calculated based on a successful new drug, its R&D expenses will be lower than this figure.

Of course, the cost of Changhua Pharmaceutical Factory's research and development of thawing spirit will not be so high, but before Su Zhe joined Changhua Pharmaceutical Factory, Li Changhua invested hundreds of millions of dollars in thawing spirit. Moreover, the final research and development results still failed, which is why the Changhua Pharmaceutical Factory was on the verge of bankruptcy.

Later, after Su Zhe brought the healing potion to join the Changhua Pharmaceutical Factory, he saved the Changhua Pharmaceutical Factory, and also made the thawing spirit rejuvenate the new year.

If the world's pharmaceutical giants develop a new drug with the same effect as Tharolytic, the retail price of a single capsule will be as low as more than 100 yuan.

Because the only role of thawing is to treat ALS, and ALS is an incurable disease in the world, and the incidence is relatively low, so it is destined that the sales volume of ALS will not be too high, so no pharmaceutical company really develops drugs for the treatment of ALS, because this is for pharmaceutical giants who have the ability to research and develop. It's not very profitable, and the risks to take are high.

So even after the development of it. The price will also be very expensive, high risk means high return, if the profit is not high, there will be no pharmaceutical company to take this risk to develop at all, which is already the default in the drug market.

Before the Thaw Spirit was officially put on sale, some well-known media and experts began to predict it, and even some well-known pharmaceutical companies in the world participated in it.

After the Changhua Pharmaceutical Factory held a press conference and also announced the effect of Defrosting Spirit, everyone thought that the final retail price of a single Thawing Spirit would be at least 100 yuan, even if it was higher than this price, they would not find it strange.

Because so far, no pharmaceutical company has developed a similar drug that can compete with Tharolytic, and in the case that Thalyphin has no rival, Changhua Pharmaceutical Factory has a lot of say in the pricing of Thalyphin in the market, and in the end, patients have to buy it.

But yesterday, when the thawing spirit was officially put on the shelves, everyone fell through the glasses and shouted that it was impossible, because the retail price of the thawing spirit was only 200 yuan for a box, and the retail price of a single pill was 20 yuan, which made experts and the media, as well as other pharmaceutical companies, feel incredible.

Almost everyone thinks that Changhua Pharmaceutical Factory will not be able to recover the research and development costs of Tharolytic, and they all feel that it is a pity, and even some media have hyped it up after knowing the news, thinking that it is impossible for Changhua Pharmaceutical Factory to keep the price of Thawing Ling for a long time, because this will make Changhua Pharmaceutical Factory unable to recover the cost.

In fact, other people don't know the real R&D cost of the Thawing Spirit, they all think that the R&D cost of the Thawing Spirit is at least billions of dollars, and even the core R&D members of the Thawing Spirit don't know the final R&D cost, because they don't know what the R&D cost of the most important healing potion in the Thawing Spirit ingredient is.

The real R&D cost of Thawing Ling is dozens of times lower than the cost predicted by others, which they can never imagine, so they think that the price of Changhua Pharmaceutical Factory is too low, and it will lead to the inability to recover the R&D cost.

But no matter what, the price of the thawing spirit is given in this way, and if there is no accident, the price of the thawing spirit will never change.

Although Su Zhe usually does not manage Changhua Pharmaceutical Factory and rarely interferes in the operation of Changhua Pharmaceutical Factory, for Changhua Pharmaceutical Factory, the biggest voice is still in Su Zhe's hands.

Because Su Zhe is not only the largest shareholder of Changhua Pharmaceutical Factory, he alone owns 85% of the shares of Changhua Pharmaceutical Factory, and he also has the hole card of healing potion.

All the development of Changhua Pharmaceutical Factory is based on healing potions, as long as Su Zhe has healing potions for one day, then the decision-making of Changhua Pharmaceutical Factory will be led by Su Zhe for one day.

Although Su Zhe knew that if he raised the price of the Thawing Spirit, he might be able to make a hundred times more profit as a result, but he didn't do so.

The reason why Su Zhe did not choose to do this was simply because he was not a pure businessman and capitalist.

Making money with a clear conscience, maybe some people can do it with peace of mind, but Su Zhe can't pass this level in his heart.

Of course, Su Zhe is not a dictator, and he also knows that he is not professional enough for Li Changhua and them in this pharmaceutical industry, and if he acts arbitrarily, it will only be bad for Changhua Pharmaceutical Factory.

Therefore, Su Zhe will refer to Li Changhua's professional opinions before making this decision, and in normal times, most of Su Zhe will not interfere in the operation and management of Changhua Pharmaceutical Factory. (To be continued......)